YaSheng Group
HERB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14 | $10 | $16 | $14 |
| - Cash | $9 | $6 | $4 | $4 |
| + Debt | $0 | $2 | $2 | $2 |
| Enterprise Value | $6 | $6 | $14 | $12 |
| Revenue | $24 | $21 | $19 | $14 |
| % Growth | 14.2% | 13.7% | 32.6% | – |
| Gross Profit | $8 | $7 | $6 | $4 |
| % Margin | 33.5% | 33.3% | 30.1% | 28.6% |
| EBITDA | $8 | $7 | $5 | $4 |
| % Margin | 31.7% | 35.1% | 28% | 26.8% |
| Net Income | $8 | $7 | $5 | $4 |
| % Margin | 33.4% | 33.2% | 28.6% | 26.5% |
| EPS Diluted | 0.051 | 0.045 | 0.034 | 0.022 |
| % Growth | 15% | 32% | 57.2% | – |
| Operating Cash Flow | $5 | $4 | $2 | $2 |
| Capital Expenditures | -$3 | -$1 | -$2 | -$1 |
| Free Cash Flow | $3 | $3 | $0 | $2 |